It has been reported that liposomal vaccines can carry both Th and cytotoxic T lymphocyte epitopes and activate both CD4+ and CD8+ T cells, producing specific anti-tumor immune response in mice models with therapeutic and preventive effects (Zamani et al., 2019; Zamani et al., 2020). Here, CD8A is linked to neoplasm.